Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
Year: 2018
Type: article
Study design: Clinical Trial
Source: Gastric Cancer
Authors: Sebastian Mondaca, Matthew Margolis, Francisco Sanchez-Vega, Philip Jonsson, Jamie C. Riches, Geoffrey Y. Ku, Jaclyn F. Hechtman, Yaelle Tuvy, Michael F. Berger, Manish A. Shah, David P. Kelsen, David H. Ilson, Kenneth Yu, Zoe Goldberg, Andrew S. Epstein, Avni Desai, Vincent Chung, Joanne F. Chou, Marinela Capanu, David B. Solit, Nikolaus Schultz, Yelena Y. Janjigian
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Award: Cancer Center Support Grant
OpenAlex ID: W2887352196